Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices 5263 

Occupational Safety and Health Act of 

1970 (OSH Act) (29 U.S.C. 651 et seq.) 

(see also 29 CFR 1911.10 and 1912.3). In 

addition, the CSA and OSHA 

regulations require the Assistant 

Secretary to consult with ACCSH before 

the agency proposes occupational safety 

and health standards affecting 

construction activities (40 U.S.C. 3704; 

29 CFR 1911.10). 

ACCSH operates in accordance with 

the Federal Advisory Committee Act 

(FACA), as amended (5 U.S.C. app. 2), 

and its implementing regulations (41 

CFR 102–3 et seq.); and Department of 

Labor Manual Series Chapter 1–900 (3/ 

25/2022). ACCSH generally meets two 

to four times a year. 

II. Meetings 

ACCSH Meeting 

ACCSH will meet from 9 a.m. to 4 

p.m., ET, Thursday, February 22, 2024. 

The meeting is open to the public. 

Meeting agenda: The tentative agenda 

for this meeting includes: 

• Assistant Secretary’s agency update 

and remarks; 

• Directorate of Construction industry 

update; 

• Women in construction discussion; 

• ACCSH Workgroup reports; and 

• Public comment period. 

ACCSH Workgroup Meetings 

In conjunction with the ACCSH 

meeting, ACCSH Workgroups will meet 

on Wednesday, February 21, 2024. 

ACCSH Workgroup meetings are open 

to the public. 

• Emerging Technology 9 a.m. to 11 

p.m. 

• Workzone 12 p.m. to 2 p.m. 

• Health in Construction 2:10 to 4:10 

p.m. 

III. Meeting Information 

The ACCSH Committee and ACCSH 

Workgroups will meet in Conference 

Room C–5521, Room 4, U.S. Department 

of Labor, 200 Constitution Avenue NW, 

Washington, DC 20210. Public 

attendance at the ACCSH Committee 

and Workgroup meetings will be inperson and virtual. In-person attendance 

will be limited to the first 25 people 

who register to attend the meetings in 

person. Please contact Ms. Gretta 

Jameson, OSHA, Directorate of 

Construction, U.S. Department of Labor; 

telephone (202) 693–2020; email: 

jameson.grettah@dol.gov, to register. Inperson meeting attendance registration 

must be completed by Thursday, 

February 15, 2024. Meeting in-person 

attendees must use the visitor’s entrance 

located at 3rd & C Streets, NW. Virtual 

meeting attendance information will be 

posted in the Docket (Docket No. 

OSHA–2024–0002) and on the ACCSH 

website, https://www.osha.gov/

advisorycommittee/accsh, prior to the 

meeting. 

Requests to speak and speaker 

presentations: Attendees who wish to 

address ACCSH must submit a request 

to speak, as well as any written or 

electronic presentation, by Thursday, 

February 15, 2024, using the method 

listed in the ADDRESSES section of this 

notice. The request must state: 

• The amount of time requested to 

speak; 

• The interest you represent (e.g., 

business, organization, affiliation), if 

any; and 

• A brief outline of your presentation. 

PowerPoint presentations and other 

electronic materials must be compatible 

with PowerPoint 2010 and other 

Microsoft Office 2010 formats. 

Alternately, you may request to 

address ACCSH briefly during the 

public-comment period. At her 

discretion, the ACCSH Chair may grant 

requests to address ACCSH as time and 

circumstances permit. 

Docket: OSHA will place comments, 

requests to speak, and speaker 

presentations, including any personal 

information you provide, in the public 

docket without change, and those 

documents may be available online at: 

http://www.regulations.gov. Therefore, 

OSHA cautions interested parties about 

submitting personal information such as 

Social Security Numbers and birthdates. 

OSHA also places in the public docket 

the meeting transcript, meeting minutes, 

documents presented at the meeting, 

and other documents pertaining to the 

ACCSH meeting. These documents are 

available online at: http://

www.regulations.gov. To read or 

download documents in the public 

docket for this ACCSH meeting, go to 

Docket No. OSHA–2024–0002 at: http:// 

www.regulations.gov. All documents in 

the public docket are listed in the index; 

however, some documents (e.g., 

copyrighted material) are not publicly 

available to read or download through 

http://www.regulations.gov. All 

submissions are available for inspection 

and copying, when permitted, at the 

OSHA Docket Office. For information 

on using http://www.regulations.gov to 

make submissions or to access the 

docket, click on the ‘‘Help’’ tab at the 

top of the homepage. Contact the OSHA 

Docket Office at (202) 693–2350, (TTY 

(877) 889–5627) for information about 

materials not available through that 

website and for assistance in using the 

internet to locate submissions and other 

documents in the docket. 

Authority and Signature 

James S. Frederick, Deputy Assistant 

Secretary of Labor for Occupational 

Safety and Health, authorized the 

preparation of this notice pursuant to 29 

U.S.C. 655, 40 U.S.C. 3704, Secretary of 

Labor’s Order No. 8–2020 (85 FR 

58393), 5 U.S.C. app. 2, and 29 CFR part 

1912. 

Signed at Washington, DC, on January 19, 

2024. 

James S. Frederick, 

Deputy Assistant Secretary of Labor for 

Occupational Safety and Health. 

[FR Doc. 2024–01534 Filed 1–25–24; 8:45 am] 

BILLING CODE 4510–26–P 

DEPARTMENT OF LABOR 

Office of the Worker’s Compensation 

Programs 

[OMB Control No. 1240–0055] 

Proposed Extension of Information 

Collection; [Authorization and 

Certification/Letter of Medical 

Necessity (CA–26/CA–27) 

AGENCY: Division of Federal Employees’ 

Longshore and Harbor Workers’ 

Compensation, Office of Workers’ 

Compensation, (OWCP/DFELHWC), 

Labor. 

ACTION: Request for public comments. 

SUMMARY: The Department of Labor, as 

part of its continuing effort to reduce 

paperwork and respondent burden, 

conducts a pre-clearance request for 

comment to provide the general public 

and Federal agencies with an 

opportunity to comment on proposed 

collections of information in accordance 

with the Paperwork Reduction Act of 

1995. This request helps to ensure that: 

requested data can be provided in the 

desired format; reporting burden (time 

and financial resources) is minimized; 

collection instruments are clearly 

understood; and the impact of collection 

requirements on respondents can be 

properly assessed. Currently, OWCP/ 

DFELHWC is soliciting comments on 

the information collection for 

Authorization and Certification/Letter of 

Medical Necessity, CA–26/CA–27. 

DATES: All comments must be received 

on or before March 26, 2024. 

ADDRESSES: You may submit comment 

as follows. Please note that late, 

untimely filed comments will not be 

considered. 

Written/Paper Submissions: Submit 

written/paper submissions in the 

following way: 

• Mail/Hand Delivery: Mail or visit 

DOL- OWCP/DFELHWC, Office of 


lotter on DSK11XQN23PROD with NOTICES1
5264 Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices 

Workers’ Compensation Programs, 

Division of Federal Employees’ 

Longshore and Harbor Workers’ 

Compensation, U.S. Department of 

Labor, 200 Constitution Ave. NW, Room 

S–3323, Washington, DC 20210. 

• OWCP/DFELHWC will post your 

comment as well as any attachments, 

except for information submitted and 

marked as confidential, in the docket at 

https://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Anjanette Suggs, Office of Workers’ 

Compensation Programs, Division of 

Federal Employees Longshore, and 

Harbor Workers’ Compensation, OWCP/ 

DFELHWC, at suggs.anjanette@dol.gov 

(email); (202) 354–9660. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In 2013, the President of the United 

States, Barack Obama, signed a law 

which provides greater Federal 

oversight over compounding 

pharmacies that custom mix medication 

in bulk for patients who may benefit 

from prescriptions that are specific to 

their individual medical needs. See 

Compounding Quality Act, Public Law 

113–54, 127 Stat. 587 (2013). 

Compounded medications (which may 

contain opioids) have two or more 

ingredients and are offered as an 

alternative to FDA-approved 

medications that do not meet an 

individual patient’s health needs, such 

as when a patient has an allergy that 

requires a medication to be made 

without a certain dye. See 

Compounding and the FDA: Questions 

and Answers, FDA, http://www.fda.gov/ 

Drugs/GuidanceComplianceRegulatory

Information/PharmacyCompounding/ 

ucm339764.htm. 

The President had previously 

announced in October 2015 that several 

initiatives would be undertaken by the 

Federal Government as it related to 

opioid abuse and the heroin epidemic, 

noting that the Centers for Disease 

Control and Prevention (CDC) reported 

that overdose deaths involving 

prescription opioids quadrupled 

between 1999 and 2013, with more than 

16,000 deaths in 2013. The CDC has 

identified addiction to prescription pain 

medication as the strongest risk factor 

for heroin addiction. 

On March 23, 2016, the President, 

responding to the escalation of 

prescription opioid abuse and the 

heroin epidemic, announced several 

actions taken by his Administration to 

address the epidemic, including steps to 

expand access for treatment, prevent 

overdose deaths and increase 

community prevention strategies. 

Compounded drugs are not FDAapproved. This means that the FDA 

does not verify the safety or 

effectiveness of compounded drugs. 

Consumers and health professionals rely 

on the drug approval process to ensure 

that drugs are safe and effective and 

made in accordance with Federal 

quality standards. Compounded drugs 

also lack an FDA finding of 

manufacturing quality before such drugs 

are marketed. 

Health risks associated with 

compounded drugs include the use of 

ingredients that may be sub- or superpotent, contaminated, or otherwise 

adulterated. Additionally, patients may 

use ineffective compounded drugs 

instead of FDA-approved drugs that 

have been shown to be safe and 

effective. 

Impacts on the FECA Program 

The Federal Employees’ 

Compensation Act (FECA), 5 U.S.C. 

8101 et seq., provides compensation 

benefits to Federal employees for workrelated injury/illness and to their 

surviving dependents if a work-related 

injury/illness results in the employee’s 

death. Section 8145 provides the 

Secretary of Labor the authority to 

delegate the responsibility to administer 

the FECA program to OWCP; through 

this delegation OWCP has the authority 

and the responsibility to decide all 

questions arising under the FECA. 5 

U.S.C. 8145. 

Section 8103 provides: 

The United States shall furnish to an 

employee who is injured while in the 

performance of duty, the services, 

appliances, and supplies prescribed or 

recommended by a qualified physician, 

which the Secretary of Labor considers 

likely to cure, give relief, reduce the 

degree or the period of disability, or aid 

in lessening the amount of the monthly 

compensation. 5 U.S.C. 8103. 

A number of injured workers 

receiving benefits under the FECA 

program are prescribed opioid 

medication. While most prescriptions 

are short term in nature, some patients 

remain on these habit-forming 

medications for a long period of time. 

Statutorily, FECA is mandated to 

provide medically necessary supplies 

and services to treat work related 

injuries. However, the FECA statute 

gives broad discretionary authority to 

determine the medical necessity of 

supplies and services used to treat work 

related injuries. Due to the safety 

concerns for both compounded drugs 

and opioids, the Department of Labor 

has deemed it necessary to more closely 

review the medical necessity of these 

medications in FECA claims by 

instituting a pre-authorization process. 

OWCP believes that the two forms 

used to monitor compound and opiate 

medication further strengthens medical 

management procedures for prescription 

drugs, assist our stakeholders in 

controlling costs from medically 

unnecessary treatments, and lessen the 

impact of potential drug addiction and 

medical fraud. 

A major goal of the FECA program is 

to return an injured employee back to 

employment as soon as medically 

feasible. The forms that are in use serve 

as a means for injured workers to 

continue receiving opioids and 

compounded drugs only where 

medically necessary and simultaneously 

give OWCP greater oversight in 

monitoring their use. 

OWCP has issued regulations relating 

to its authority to require prior 

authorization for medical treatment 

which will now be applied through 

these forms to compounded drugs and 

opioids. (20 CFR 10.310, 10.800 & 10. 

809). Requiring Prior Authorization will 

assist OWCP in determining whether 

the prescribed medication will assist in 

curing, giving relief, and lessening the 

degree of disability. FECA further 

provides OWCP the authority to 

conduct such investigation as necessary 

before making an award of 

compensation (including the need for 

medical treatment by certain 

prescription drugs). 5 U.S.C. 8124(a)(2). 

Finally, 5 U.S.C. 8149 provides OWCP 

the authority to prescribe rules and 

regulations necessary for the 

administration of FECA. 

As such, the CA–26, Authorization 

Request form and Certification/Letter of 

Medical Necessity for Compounded 

Drugs, and CA–27, Authorization 

Request form and Certification/Letter of 

Medical Necessity or Opioid 

Medications, fulfill these requirements 

and obligations under the FECA. 

II. Desired Focus of Comments 

OWCP is soliciting comments 

concerning the proposed information 

collection (ICR) titled, ‘‘Authorization 

and Certification/Letter of Medical 

Necessity’’, CA–26/CA–27. 

OWCP/DFELHWC is particularly 

interested in comments that: 

• Evaluate whether the collection of 

information is necessary for the proper 

performance of the functions of the 

Agency, including whether the 

information has practical utility; 

• Evaluate the accuracy of OWCP/ 

DFELHWC’s estimate of the burden 

related to the information collection, 

including the validity of the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices 5265 

methodology and assumptions used in 

the estimate; 

• Suggest methods to enhance the 

quality, utility, and clarity of the 

information to be collected; and 

• Minimize the burden of the 

information collection on those who are 

to respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of responses. 

Background documents related to this 

information collection request are 

available at https://regulations.gov and 

at DOL–OWCP/DFELHWC located at 

200 Constitution Avenue NW, Room S– 

3323, Washington, DC 20210. Questions 

about the information collection 

requirements may be directed to the 

person listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice. 

III. Current Actions 

This information collection request 

concerns the Authorization and 

Certification/Letter of Medical 

Necessity, CA–26/CA–27. 

OWCP/DFELHWC has updated the 

data with respect to the number of 

respondents, responses, burden hours, 

and burden costs supporting this 

information collection request from the 

previous information collection request. 

Type of Review: Extension, without 

change, of a currently approved 

collection. 

Agency: Office of Workers’ 

Compensation Programs, Division of 

Federal Employees’ Longshore, and 

Harbor Workers’ Compensation, OWCP/ 

DFELHWC. 

OMB Number: 1240–0055. 

Affected Public: Individuals or 

households; business or other for-profit. 

Number of Respondents: 1,104. 

Frequency: On occasion. 

Number of Responses: 4,212. 

Annual Burden Hours: 2,106 hours. 

Annual Respondent or Recordkeeper 

Cost: $241,685.00. 

OWCP Form CA–26/CA–27, 

Authorization and Certification/Letter of 

Medical Necessity. 

Comments submitted in response to 

this notice will be summarized in the 

request for Office of Management and 

Budget approval of the proposed 

information collection request; they will 

become a matter of public record and 

will be available at https://

www.reginfo.gov. 

Anjanette Suggs, 

Certifying Officer. 

[FR Doc. 2024–01535 Filed 1–25–24; 8:45 am] 

BILLING CODE 4510–CH–P 

NATIONAL AERONAUTICS AND 

SPACE ADMINISTRATION 

[Notice: 24–005] 

Information Collection: NASA New 

Technology Reporting System 

AGENCY: National Aeronautics and 

Space Administration (NASA). 

ACTION: Notice of information collection; 

renewal of existing approved collection. 

SUMMARY: The National Aeronautics and 

Space Administration, as part of its 

continuing effort to reduce paperwork 

and respondent burden, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. 

DATES: Comments are due by March 26, 

2024. 

ADDRESSES: Written comments and 

recommendations for this information 

collection should be sent within 60 days 

of publication of this notice to 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

60-day Review-Open for Public 

Comments’’ or by using the search 

function. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information or 

copies of the information collection 

instrument(s) and instructions should 

be directed to NASA PRA Clearance 

Officer, Bill Edwards-Bodmer, NASA 

Headquarters, 300 E Street SW, JF0000, 

Washington, DC 20546, phone 757–864– 

7998, or email hq-ocio-pra-program@

mail.nasa.gov. 

SUPPLEMENTARY INFORMATION: 

I. Abstract 

Personnel performing research and 

development are required by statutes, 

NASA implementing regulations, and 

OMB policy to submit reports of 

inventions, patents, data, and 

copyrights, including the utilization and 

disposition of same. The NASA New 

Technology Summary Report reporting 

form is being used for this purpose. This 

information is required to ensure the 

proper disposition of rights to 

inventions made in the course of NASAfunded research contracts. The 

requirement is codified in 48 CFR part 

1827. The legislative authorities are 42 

U.S.C. 2457 et seq., and 35 U.S.C. 200 

et seq. 

II. Methods of Collection 

NASA FAR Supplement clauses for 

patent rights and new technology 

encourage personnel to use an 

electronic form and provide a hyperlink 

to the electronic New Technology 

Reporting System (e-NTR) site: http://

invention.nasa.gov. This website has 

been set up to help NASA employees 

and parties under NASA funding 

agreements (i.e., contracts, grants, 

cooperative agreements, and 

subcontracts) to report new technology 

information directly to NASA via a 

secure internet connection. 

III. Data 

Title: NASA New Technology 

Reporting System. 

OMB Number: 2700–0052. 

Type of Review: Extension of a 

currently approved collection. 

Affected Public: Businesses, colleges 

and university, and/or other for-profit 

institutions. 

Estimated Annual Number of 

Activities: 3,372. 

Estimated Number of Respondents 

per Activity: 1. 

Annual Responses: 3,372. 

Estimated Time per Response: 3 

hours. 

Estimated Total Annual Burden 

Hours: 10,116. 

IV. Request for Comments 

Comments are invited on: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of NASA, including 

whether the information collected has 

practical utility; (2) the accuracy of 

NASA’s estimate of the burden 

(including hours and cost) of the 

proposed collection of information; (3) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) ways to minimize the 

burden of the collection of information 

on respondents, including automated 

collection techniques or the use of other 

forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the request for OMB 

approval of this information collection. 

They will also become a matter of 

public record. 

William Edwards-Bodmer, 

NASA PRA Clearance Officer. 

[FR Doc. 2024–01286 Filed 1–25–24; 8:45 am] 

BILLING CODE 7510–13–P 

NATIONAL COUNCIL ON DISABILITY 

Sunshine Act Meetings 

TIME AND DATE: The Members of the 

National Council on Disability (NCD) 

will hold a quarterly business meeting 


lotter on DSK11XQN23PROD with NOTICES1